Privia Health Group Inc Receivables Turnover Ratio (PRVA), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Privia Health Group Inc   (NASDAQ: PRVA)
 

Privia Health Group Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Privia Health Group Inc 's ability to collect accounts receivable sequentially worsen to 4.75, pointing to a challenging and on top of that deteriorating business climate for the Medical Equipment & Supplies industry. Privia Health Group Inc 's Accounts Receivable average collection period in the Jun 30 2026 quarter, has increased to 77 days, from 75 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 386 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 250 to 2723.

What is Receivable Turnover Ratio?
What is Privia Health Group Inc Selling?


What is Receivable Turnover Ratio?





PRVA Receivables Turnover Ratio (Jun 30 2026)
II. Quarter
(Mar 31 2026)
I. Quarter
(Dec 31 2025)
IV. Quarter
(Sep 30 2025)
III. Quarter
(Jun 30 2025)
II. Quarter
Y / Y Receivable Change 29.32 % 32.14 % 26.8 % 22.03 % 19.98 %
Y / Y Revenue Change 21.39 % 25.78 % 17.42 % 32.54 % 23.4 %
Receivable Turnover Ratio (TTM) 4.75 4.84 4.9 4.96 4.88
PRVA's Total Ranking # 2723 # 250 # 163 # 276 # 2423
Accounts Receivable average collection period days 77 75 74 74 75
Seq. Receivable Change 11.77 % 28.13 % -19.67 % 12.4 % 14.22 %
Seq. Revenue Change 4.77 % 11.58 % -6.76 % 11.37 % 8.55 %


Receivable Turnover Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 143
Healthcare Sector # 387
Overall Market # 2723

Receivable Turnover Ratio Statistics
High Average Low
8.41 5.95 4.82
(Dec 31 2021)   (Dec 31 2024)






Financial Statements
Privia Health Group Inc 's Accounts Receivable $ 574 Millions Visit PRVA's Balance sheet
Privia Health Group Inc 's Sales TTM $ 2,358 Millions Visit PRVA's Income Statement
Sources of PRVA's Revenues Visit PRVA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Equipment & Supplies Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
PRVA's Receivable Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
PRVA's Growth Rates PRVA's Roa PRVA's Inventory Turnover Ratio PRVA's Dividend Comparisons
PRVA's Profitability Ratios PRVA's Roi PRVA's Asset Turnover Ratio PRVA's Dividend Growth
PRVA's Valuation Ratios PRVA's Roe PRVA's Financial Strength Ratios PRVA's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 30 2026 Receivable at quarter ending Jun 30 2026
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions
International Stem Cell Corporation  10.91 $ 9.514  Millions$ 0.872  Millions
Premier Air Charter Holdings Inc   10.66 $ 31.562  Millions$ 2.961  Millions
C4 Therapeutics Inc   10.65 $ 35.039  Millions$ 3.290  Millions
Lifeloc Technologies Inc   10.48 $ 9.269  Millions$ 0.884  Millions
Immucell Corporation  10.29 $ 29.777  Millions$ 2.893  Millions
Addus Homecare Corp  10.23 $ 1,475.610  Millions$ 144.195  Millions
Dariohealth Corp   10.23 $ 21.196  Millions$ 2.072  Millions
Radnet Inc   10.11 $ 2,268.932  Millions$ 224.447  Millions
Utah Medical Products Inc  9.88 $ 35.679  Millions$ 3.612  Millions
Lensar Inc   9.75 $ 60.264  Millions$ 6.184  Millions
Biolife Solutions Inc   9.67 $ 102.718  Millions$ 10.626  Millions
Encompass Health Corporation  9.57 $ 6,206.100  Millions$ 648.325  Millions
The Oncology Institute Inc   9.57 $ 587.244  Millions$ 61.364  Millions
Alumis inc   9.44 $ 7.398  Millions$ 0.784  Millions
Enanta Pharmaceuticals Inc  9.29 $ 65.258  Millions$ 7.027  Millions
Neuronetics Inc   9.24 $ 154.594  Millions$ 16.732  Millions
Harmony Biosciences Holdings inc   9.22 $ 960.191  Millions$ 104.164  Millions
Pavmed Inc   9.16 $ 0.126  Millions$ 0.014  Millions
Ardent Health Inc   9.16 $ 6,405.940  Millions$ 699.363  Millions
Bioaffinity Technologies Inc   9.11 $ 5.901  Millions$ 0.648  Millions
Sunshine Biopharma Inc   9.03 $ 35.347  Millions$ 3.916  Millions
Biofrontera Inc   8.88 $ 45.956  Millions$ 5.178  Millions
Grail Inc   8.85 $ 165.263  Millions$ 18.670  Millions
Guardant Health Inc   8.84 $ 1,183.105  Millions$ 133.772  Millions
Scientific Industries Inc   8.83 $ 5.728  Millions$ 0.649  Millions
Sanara Medtech Inc   8.76 $ 110.116  Millions$ 12.568  Millions
Cannapharmarx Inc   8.65 $ 1.699  Millions$ 0.196  Millions
Fate Therapeutics Inc   8.64 $ 6.491  Millions$ 0.751  Millions
Septerna Inc   8.64 $ 98.882  Millions$ 11.445  Millions

Date modified: 2026-09-05T15:26:56+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.